Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 4:37 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 26-Feb-24 | Sale (Planned) | 5,034 | $425.70 | $2,142,970.00 | (9%) 54.87K to 49.83K | |
| 27-Feb-24 4:37 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 4,714 | $431.79 | $2,035,460.00 | (8%) 59.58K to 54.87K | |
| 23-Feb-24 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-24 | Private Sale (Planned) | 3,603 | $421.77 | $1,519,640.00 | (6%) 63.18K to 59.58K | |
| 21-Feb-24 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 3,373 | $420.58 | $1,418,620.00 | (5%) 71.36K to 67.99K | |
| 21-Feb-24 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Sale (Planned) | 4,804 | $420.79 | $2,021,480.00 | (7%) 67.99K to 63.18K | |
| 21-Feb-24 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 4,499 | $424.01 | $1,907,620.00 | (6%) 75.86K to 71.36K | |
| 13-Feb-24 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 4,295 | $420.24 | $1,804,930.00 | (5%) 80.15K to 75.86K | |
| 12-Feb-24 4:41 PM View: | Immunogen Inc. (IMGN) | 12-Feb-24 | Disposition | 5,381 | -- | -- | (100%) 5.38K to 0 | |
| 13-Feb-24 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 3,177 | $422.74 | $1,343,040.00 | (4%) 83.33K to 80.15K | |
| 08-Feb-24 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 8,448 | -- | -- | 11% 74.88K to 83.33K | |
| 08-Feb-24 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 18,186 | -- | -- | 32% 56.7K to 74.88K | |
| 03-Jan-24 5:43 PM View: | Immunogen Inc. (IMGN) | 29-Dec-23 | Grant | 442 | $29.65 | $13,105.30 | 9% 4.94K to 5.38K | |
| 15-Dec-23 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Dec-23 | Option Exercise | 8,603 | $187.53 | $1,613,320.00 | 15% 56.7K to 65.3K | (10%) |
| 15-Dec-23 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Dec-23 | Planned Private Option Sale | 8,603 | $399.00 | $3,432,600.00 | (13%) 65.3K to 56.7K | |
| 02-Oct-23 10:00 PM View: | Immunogen Inc. (IMGN) | 29-Sep-23 | Grant | 827 | $15.87 | $13,124.50 | 20% 4.11K to 4.94K | |
| 05-Jul-23 5:54 PM View: | Immunogen Inc. (IMGN) | 30-Jun-23 | Grant | 695 | $18.87 | $13,114.70 | 20% 3.42K to 4.11K | |
| 20-Jun-23 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Jun-23 | Option Exercise | 8,603 | $187.53 | $1,613,320.00 | 15% 56.7K to 65.3K | (10%) |
| 20-Jun-23 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Jun-23 | Planned Private Option Sale | 8,603 | $349.00 | $3,002,450.00 | (13%) 65.3K to 56.7K | |
| 01-Jun-23 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-May-23 | Private Sale (Planned) | 82 | $329.82 | $27,045.20 | (< 1%) 56.78K to 56.7K | |
| 04-Apr-23 4:52 PM View: | Immunogen Inc. (IMGN) | 31-Mar-23 | Grant | 3,417 | $3.84 | $13,121.30 | 100% 0 to 3.42K | |
| 28-Feb-23 4:47 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Feb-23 | Sale (Planned) | 5,034 | $287.47 | $1,447,140.00 | (8%) 61.73K to 56.7K | |
| 28-Feb-23 4:47 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 4,714 | $289.12 | $1,362,910.00 | (7%) 66.44K to 61.73K | |
| 24-Feb-23 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 22-Feb-23 | Private Sale (Planned) | 2,401 | $294.33 | $706,679.00 | (3%) 68.84K to 66.44K | |
| 22-Feb-23 4:30 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-23 | Sale (Planned) | 2,402 | $293.75 | $705,596.00 | (3%) 71.25K to 68.84K | |
| 22-Feb-23 4:30 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 4,498 | $292.85 | $1,317,240.00 | (6%) 75.75K to 71.25K | |
| 16-Feb-23 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Feb-23 | Private Sale (Planned) | 6,398 | $298.68 | $1,910,960.00 | (8%) 82.14K to 75.75K | |
| 14-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 5,990 | $298.26 | $1,786,580.00 | (6%) 93.02K to 87.03K | |
| 14-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Sale (Planned) | 4,887 | $298.92 | $1,460,820.00 | (6%) 87.03K to 82.14K | |
| 14-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 3,372 | $294.33 | $992,481.00 | (3%) 96.39K to 93.02K | |
| 03-Feb-23 4:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 38,221 | -- | -- | 66% 58.17K to 96.39K | |
| 08-Dec-22 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Dec-22 | Grant | 12,753 | -- | -- | 28% 45.42K to 58.17K | |
| 17-Aug-22 5:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Aug-22 | Option Exercise | 6,571 | $155.57 | $1,022,250.00 | 11% 61.02K to 67.59K | |
| 17-Aug-22 5:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Aug-22 | Planned Option Sale | 6,571 | $303.93 | $1,997,110.00 | (10%) 67.59K to 61.02K | |
| 17-Aug-22 5:39 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Aug-22 | Sale (Planned) | 15,602 | $303.93 | $4,741,880.00 | (26%) 61.02K to 45.42K | |
| 12-Aug-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-22 | Option Exercise | 64 | $155.57 | $9,956.48 | < 1% 61.14K to 61.2K | |
| 12-Aug-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-22 | Planned Option Sale | 64 | $300.40 | $19,225.90 | (< 1%) 61.2K to 61.14K | |
| 12-Aug-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-22 | Sale (Planned) | 116 | $300.40 | $34,846.90 | (< 1%) 61.14K to 61.02K | |
| 10-Aug-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Aug-22 | Option Exercise | 1,926 | $155.57 | $299,628.00 | 3% 64.9K to 66.83K | |
| 10-Aug-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Aug-22 | Planned Option Sale | 1,926 | $300.67 | $579,092.00 | (3%) 66.83K to 64.9K | |
| 10-Aug-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Aug-22 | Sale (Planned) | 3,764 | $300.67 | $1,131,720.00 | (6%) 64.9K to 61.14K | |
| 18-May-22 4:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-May-22 | Private Sale (Planned) | 133 | $251.19 | $33,408.30 | (< 1%) 65.03K to 64.9K | |
| 04-May-22 5:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-22 | Private Sale (Planned) | 306 | $263.98 | $80,777.90 | (< 1%) 65.21K to 64.9K | |
| 28-Feb-22 5:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 7,246 | $227.86 | $1,651,070.00 | (10%) 72.45K to 65.21K | |
| 22-Feb-22 4:54 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 4,126 | $232.51 | $959,336.00 | (5%) 76.58K to 72.45K | |
| 14-Feb-22 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 3,040 | $237.74 | $722,730.00 | (4%) 79.62K to 76.58K | |
| 03-Feb-22 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 38,375 | -- | -- | 93% 41.24K to 79.62K | |
| 16-Nov-21 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-21 | Private Sale (Planned) | 3 | $187.26 | $561.78 | (< 1%) 41.25K to 41.24K | |
| 19-May-21 4:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-May-21 | Private Sale (Planned) | 109 | $216.41 | $23,588.70 | (< 1%) 41.35K to 41.24K | |
| 26-Feb-21 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-21 | Sale (Planned) | 3,634 | $213.54 | $775,989.00 | (8%) 44.88K to 41.24K | |
| 26-Feb-21 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 2,898 | $217.57 | $630,518.00 | (6%) 47.77K to 44.88K |